FORM 10-Q - IGC Pharma, INC.

SEC

Filings

February 18, 2025

FORM 10-Q

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma, Inc. Form S-3A 12-3-25

December 3, 2025

IGC Pharma, Inc. Form S-3 11-14-25

November 14, 2025

IGC Pharma, Inc. Form 8-K 11-14-25

November 14, 2025

CEO Update

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.”

December 10, 2025

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer’s Agitation Trial

December 9, 2025